RPS6KB1 and neoplasm: Under certain circumstances, DEPTOR overexpression inhibits S6K1, an mTORC1 substrate, and alleviates S6K-mediated IRS-1/PI3K (phosphoinositide 3 kinase)-dependent negative feedback to activate AKT, leading to cell survival, which facilitates tumor progression2–4.